Duke Early Phase Clinical Research — Durham, North Carolina

Duke Early Phase Clinical Research is a clinical research site located in Durham, North Carolina, United States 27701.

Crixeo Clinical Trials Trust Score: 16/100 (FAILING). This profile has not yet been claimed by the site owner.

Duke Early Phase Clinical Research has participated in 7 clinical trials with 1 currently active.

Therapeutic areas: Hyperinsulinemic Hypoglycemia, Major Depressive Disorder, Postbariatric Hypoglycemia.

Sponsors: Xeris Pharmaceuticals, National Institute of Mental Health (NIMH), Eiger BioPharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Durham

Browse all research sites in North Carolina · View every site in Durham

Sponsor Feasibility Report

Trust Score: 16/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke Early Phase Clinical Research?

Duke Early Phase Clinical Research has a Crixeo Trust Score of 16/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke Early Phase Clinical Research conducted?

Duke Early Phase Clinical Research has 7 clinical trials on record, with 1 currently active. Their work covers Hyperinsulinemic Hypoglycemia, Major Depressive Disorder, Postbariatric Hypoglycemia.

Is Duke Early Phase Clinical Research accredited by Crixeo Clinical Trials?

Duke Early Phase Clinical Research has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Duke Early Phase Clinical Research?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.